去年，Becton Dickinson and Co表現最佳的業務類別Medication Delivery Solutions的營收達到4.58B美元。United States的營收貢獻最高，去年達到12.79B美元。最近一個季度，截至2026-06-30，Becton Dickinson and Co表現最佳的業務類別Medication Delivery Solutions的營收達到1.16B美元。United States的營收貢獻最高，達到3.08B美元。

業務

營業收入

佔比

年報

年報

單季報

Medication Delivery Solutions

Medication Management Solutions

Pharmaceutical Systems

Peripheral Intervention

Specimen Management

Integrated Diagnostic Solutions

Urology and Critical Care

Surgery

Biosciences

Advanced Patient Monitoring

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Medication Delivery Solutions

4.58B(20.95%)

4.43B(21.88%)

4.29B(22.16%)

4.31B(22.83%)

4.10B(21.44%)

3.60B(22.37%)

Medication Management Solutions

3.47B(15.91%)

3.30B(16.29%)

2.98B(15.38%)

2.53B(13.42%)

2.43B(12.71%)

2.45B(15.27%)

Pharmaceutical Systems

2.32B(10.64%)

2.27B(11.23%)

2.23B(11.51%)

2.00B(10.60%)

1.83B(9.56%)

1.59B(9.87%)

Peripheral Intervention

2.00B(9.14%)

1.93B(9.55%)

1.86B(9.63%)

1.76B(9.32%)

1.71B(8.94%)

1.51B(9.40%)

Specimen Management

1.87B(8.57%)

--(--)

Integrated Diagnostic Solutions

1.84B(8.42%)

3.68B(18.17%)

3.62B(18.71%)

4.18B(22.18%)

5.22B(27.31%)

3.53B(21.97%)

Urology and Critical Care

1.65B(7.55%)

1.55B(7.68%)

1.37B(7.09%)

1.30B(6.92%)

1.23B(6.44%)

1.13B(7.03%)

Surgery

1.57B(7.20%)

1.49B(7.37%)

1.50B(7.73%)

1.40B(7.42%)

1.30B(6.77%)

1.12B(6.97%)

Biosciences

1.46B(6.68%)

1.51B(7.47%)

1.51B(7.79%)

1.38B(7.31%)

1.30B(6.82%)

1.14B(7.11%)

Advanced Patient Monitoring

1.08B(4.95%)

74.00M(0.37%)

--(--)

地區

營業收入

佔比

年報

年報

單季報

United States

International

Europe

Greater Asia

Other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

United States

12.79B(58.56%)

11.66B(57.80%)

11.11B(57.36%)

10.72B(56.82%)

10.37B(54.21%)

9.16B(57.00%)

9.73B(56.27%)

International

9.05B(41.44%)

8.52B(42.20%)

8.26B(42.64%)

8.15B(43.18%)

8.76B(45.79%)

6.91B(43.00%)

--(--)

Europe

--(--)

3.36B(19.43%)

Greater Asia

--(--)

2.73B(15.77%)

Other

--(--)

1.48B(8.54%)